Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Unique Low T treatment expected to eliminate the problematic transference side effect More
Life Science Leadership Series – Oncology
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
We have two good condition units, worth for value:
1. Complete bioBubble system of dimension 2m W x 3m L x 2.5m H (Big – RM24,500)
2. Complete Biobubble freestanding cleanroom system of dimension
1.2m W x 1m L x 2.5m H (Small – RM15,0 More
1. Complete bioBubble system of dimension 2m W x 3m L x 2.5m H (Big – RM24,500)
2. Complete Biobubble freestanding cleanroom system of dimension
1.2m W x 1m L x 2.5m H (Small – RM15,0 More
APR, the drug developer and drug delivery technology provider headquartered in Balerna, Switzerland and its partner Labtec, the drug delivery technology developer headquartered in Langenfeld, Germany announce the submission of Zolmitriptan Oral Dispersibl More
About Cerca Insights
Cerca Insights core business is helping our customers to improve their drug discovery productivity. Cerca Insights is a Contract Research Organisation (CRO) based in Penang, Malaysia. The company commenced operations in 2008 and now More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
Chakra Biotech Sdn Bhd today announced its name change to Cerca Insights Sdn Bhd. The name change follows the recent completion of a Series B investment round with Malaysian Life Sciences Capital Fund Ltd (MLSCF) and the Malaysian Technology Development C More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
Cerca Insights has been pleased to help Curemark to move one of their products towards an IND.
Click here here to view Curemark's press release in full. More
Click here here to view Curemark's press release in full. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Nov 2011 - 8 pages - $75
Jan 2006 - 21 pages - $1,100
May 2011 - 3 pages - $100
Feb 2011 - 15 pages - $125
May 2010 - 8 pages - $395
Your selection
- Industry sector
- Research tools del
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us